This randomized clinical trial of US adults treated with stable doses of glucagon-like peptide-1 and/or glucose-dependent insulinotropic polypeptide agonists examines the effects on residual gastric volume. from JAMA Internal Medicine Online First https://ift.tt/8mAlRJW

This randomized clinical trial evaluates whether weekly extended-release buprenorphine has noninferior effectiveness and safety outcomes compared with sublingual buprenorphine among pregnant adults with opioid use disorder. from JAMA Internal Medicine Online First https://ift.tt/K2sTMrQ

We sincerely thank the 1127 peer reviewers who completed manuscript reviews for JAMA Internal Medicine in 2025. from JAMA Internal Medicine Online First https://ift.tt/9Hfe5V1

This Viewpoint discusses eConsult-integrated care to improve access to specialty health care. from JAMA Internal Medicine Online First https://ift.tt/7ClBZHL

This cross-sectional study assesses the use of Medicare’s Annual Wellness Visits among older patients with Medicare Advantage and traditional Medicare coverage. from JAMA Health Forum New Online https://ift.tt/KZCHf5O

This meta-epidemiological assessment evaluates the reliability of the Global Burden of Disease risk factor estimates for mortality and disability-adjusted life-years. from JAMA Health Forum New Online https://ift.tt/Aip9r2O

This cross-sectional study quantifies federal lobbying expenditures by the hospital industry in 2024 and compares variations in lobbying expenditures by hospital ownership status. from JAMA Health Forum New Online https://ift.tt/iBlTKuH

This Viewpoint discusses the Make America Healthy Again Commission’s “Make Our Children Healthy Again” report, which implicates the food industry for its role in the chronic disease epidemic. from JAMA Health Forum New Online https://ift.tt/HWtRPKT

This JAMA Forum discusses changes under the Trump administration to the vaccination schedule, oversight of vaccine safety, the National Vaccine Injury Compensation Program, and the Vaccines for Children program. from JAMA Health Forum New Online https://ift.tt/9lXbtiy

This difference-in-differences analysis evaluates the association of the Inflation Reduction Act’s 2024 prescription drug provisions with cost-related medication nonadherence as well as health care–related financial strain. from JAMA Internal Medicine Online First https://ift.tt/4WKJmlU

This essay discusses the author’s reflection on their first night on call as a postgraduate year 1 resident. from JAMA Internal Medicine Online First https://ift.tt/BFyqGx3